Martin (Marty) is a cofounder and chief executive officer of Meissa Vaccines. Prior to cofounding Meissa, Marty was an Associate Professor at Emory University and director of the Emory Children’s Center for Childhood Infections and Vaccines (CCIV). He developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by synthetic biology. As applied to RSV vaccines, this technology was recognized as Emory University’s innovation of the year in 2013. Marty has more than 70 publications in virology, is co-inventor of 20 RSV-related technologies, and is a frequent national/international lecturer on RSV and vaccines.
Biotech 2050 Podcast